Announcements Trials
Browse Landscape

Phase

Phase 1 7Phase 2/3 3Phase NA 2Phase 2 2Phase EARLY_PHASE1 1

Status

Recruiting 3Unknown 1Completed 1

Sponsor Class

OTHER_GOV 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Pancreatic Neoplasms 1Liver Metastases 1Disease 1Colonic Neoplasms 1

Interventions

Cisplatin 22pembrolizumab 17Drug Therapy 16Carboplatin 15Paclitaxel 12Dexamethasone 12Gemcitabine 11Magnetic Resonance Spectroscopy 10Bevacizumab 10Docetaxel 9venetoclax 8atezolizumab 8Pemetrexed 8Oxaliplatin 8Specimen Handling 7Radiotherapy 7Nivolumab 7Cyclophosphamide 7Capecitabine 7Methotrexate 6130-nm albumin-bound paclitaxel 6durvalumab 5blinatumomab 5Cytarabine 5Androgen Antagonists 5tislelizumab 4spartalizumab 4pertuzumab 4Vincristine 4Trimethoprim, Sulfamethoxazole Drug Combination 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Recruiting × Positron Emission Tomography Computed Tomography × Clear all
NCT04143516 2026-03-19

Tissue Analysis After Tumor Ablation for Liver Metastases Leading to Immediate Retreatment

Memorial Sloan Kettering Cancer Center

Phase 2/3 Recruiting
200 enrolled

Liver Metastases

NCT07272772 2025-12-09

Colon Cancer Diagnosis With FAPI-PET Imaging

Turku University Hospital

Phase 2/3 Recruiting
100 enrolled
Gastrointestinal

Colonic Neoplasms

NCT07098598 2025-08-01

Pancreatic Cancer Diagnosis With FAPI-PET Imaging

Turku University Hospital

Phase 2/3 Recruiting
100 enrolled
Gastrointestinal

Disease, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡